US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist

14.220
-0.230-1.59%

Close Aug 16 16:00 ET

14.220
0.0000.00%

Post 16:01 ET

304.06MMarket Cap-301P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 2.931M	--
--	2024/Q3	-- / 2.844M	--
--	2024/Q2	33.445M / 5.506M	--
--	2024/Q1	5.840M / 0.000	--
--	2023/Q4	-- / 2.500M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 2.931M--

--2024/Q3-- / 2.844M--

--2024/Q233.445M / 5.506M--

--2024/Q15.840M / 0.000--

--2023/Q4-- / 2.500M--

Unlock Free Earnings Estimates

Open Account

Cartesian Therapeutics Earnings Reports

Cartesian Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 07:09 ET

Cartesian Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8 07:08 ET

Cartesian Therapeutics | 10-K: FY2023 Annual Report

Mar 7 07:14 ET

Cartesian Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 13, 2023 16:31 ET

Analyst Rating

Updated: Aug 17, 2024

Strong Buy

Buy
85.71%
Hold
14.29%
Sell
0.00%

Price Target

No Data

Heat List

Overall